Loading…
Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease
Highlights • The in vitro anticoagulant potency of commonly used anticoagulants is substantially different in plasma from patients with cirrhosis compared to healthy individuals • The hemostatic changes in patients with cirrhosis of different etiologies are similar but not identical • In comparing t...
Saved in:
Published in: | Thrombosis research 2017-02, Vol.150, p.41-43 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Highlights • The in vitro anticoagulant potency of commonly used anticoagulants is substantially different in plasma from patients with cirrhosis compared to healthy individuals • The hemostatic changes in patients with cirrhosis of different etiologies are similar but not identical • In comparing the anticoagulant potency of LMWH, apixaban, and dabigatran between patients with cirrhosis due to fatty liver disease or alcohol we found no differences between these distinct etiologies. |
---|---|
ISSN: | 0049-3848 1879-2472 |
DOI: | 10.1016/j.thromres.2016.12.008 |